News
Dupixent Approved to Address Unmet Needs in Chronic Hives Treatment

United States: The U.S. Food and Drug Administration (FDA) has authorized Dupixent (dupilumab) for CSU treatment in patients who are twelve years or older. The medication is now indicated for patients whose symptoms persist when using standard antihistamine treatments, as reported by HealthDay.
Efficacy Proven in Phase 3 Trials
The FDA approved Dupixent using data from two Phase 3 clinical trials that tested the drug in CSU patients who continued to suffer symptoms when taking antihistamines. Clinical trials determined that Dupixent provided additional treatment benefit by decreasing the severity of itch and urticaria activity when used together with antihistamines for 24 weeks.
Meaningful Improvement in Disease Control
By week 24, patients receiving Dupixent showed a greater likelihood of achieving well-controlled disease or a complete response, relative to those on placebo. The treatment’s safety profile remained consistent with its already approved uses in other inflammatory conditions, as reported by HealthDay.
🚨BREAKING🚨
— HCPLive (@HCPLiveNews) April 18, 2025
The FDA has approved dupilumab (#Dupixent) for the treatment of patients aged 12 years and older with #ChronicSpontaneousUrticaria (CSU) for whom CSU is uncontrolled with H1-antihistamines.
View our summary:https://t.co/YcmPbF0JCi pic.twitter.com/vAVzr9R0es
Addressing an Unmet Need in CSU Management
“Patients with chronic spontaneous urticaria who do not respond to antihistamines often suffer from persistent, disruptive symptoms,” said Alyssa Johnsen, M.D., Ph.D., Global Therapeutic Area Head for Immunology and Oncology Development at Sanofi. “This approval introduces a new treatment pathway to target the underlying mechanisms of this chronic disease.”
Sanofi now holds marketing authorization for this expanded indication of Dupixent.
News
Every U.S. Rice Sample Tested Shows Arsenic, Cadmium, or Lead

Be smart about the rice you consume and how you prepare it to reduce your loved ones’ intake of potentially dangerous heavy metals.
United States: A new study by Healthy Babies, Bright Futures has uncovered that many rice brands sold in U.S. supermarkets—especially in cities like New York and Miami—contain measurable and potentially dangerous levels of heavy metals. Every single rice sample tested had detectable arsenic, with one-quarter exceeding FDA limits set for infant rice cereal, as reported by HealthDay.
Infant Rules Don’t Apply to All
Although the FDA implemented a maximum arsenic level for infant rice cereal in 2021, no such rule exists for regular rice consumed by millions—including toddlers and young children. Researchers stress this loophole as a public health concern.
Major Brands, Major Findings
The report tested rice from 145 brands including Trader Joe’s, Ben’s, and Goya. Results showed heavy metal concentrations ranging from 63 to 188 parts per billion (ppb), with some samples reaching as high as 240 ppb. Arsenic was the most commonly found, followed by cadmium.
TOXIC ARSENIC IN RICE INCREASES WITH TEMPERATURE & CO2
— Peter D Carter (@PCarterClimate) May 16, 2025
Multiple very bad health effects.
Risk already recognized
Danger limit being exceededhttps://t.co/MIa4xewDK0#rice #climatechange. #globalwarming pic.twitter.com/Q7pTPlqcrm
Industry Response: Consumers Deserve Reassurance
The USA Rice Federation acknowledged consumer concerns but insisted current arsenic levels in rice pose no significant public health risk, as reported by HealthDay.
How to Reduce Your Risk
The report offers key tips for safer consumption:
Cook it like pasta: Drown your rice in water (6–10 cups per 1 cup of rice) and let it brew.
Switch it up: Switch to grains such as quinoa, barley, or couscous, since they contain less heavy metals.
Pick safer varieties: Look for white rice from California, sushi rice, Thai jasmine, or Basmati rice from India. Stay away from brown rice, Southern-grown white rice and arborio rice imported from Italy (Suggested Alternative: Skip those three varieties as they may contain higher levels of metals).
News
Houston Wastewater Detected Measles Weeks Before Outbreak, Study Finds

Early detection and prevention of measles can be done by monitoring for the virus in wastewater.
United States: Measles virus showed up in Houston’s sewage water several weeks before the big measles outbreak happened in Texas in January, according to a new study.
Early Warning Signs in Wastewater
Wastewater samples taken on Jan. 7 were found to have measles virus DNA in them, which was reported by scientists in the American Journal of Public Health, as reported by HealthDay.
According to the researchers, the City of Houston Health Department found and reported two cases of measles in adults not vaccinated for the disease on January 17th. The survey is based on people living in the same areas where the water treatment plants supplied water.
Measles Resurgence in Texas
In all, 717 people in Texas had measles as of May 13, reported the Texas Department of State Health Services. Two children who have not been vaccinated have died.
#Measles in the #Sewers? #WastewaterSurveillance Offers Early Warning for #Outbreaks. #Houston @BCMTailorLabs @saracregeen @MikeTisza @bcmhouston @TEPHI_Texas @RiceUNews @UTHealthSPH #AJPH https://t.co/RNxDxBIaFV @DiscoverMag pic.twitter.com/xrlAPDCbsY
— From the Labs at Baylor College of Medicine (@BCMFromtheLabs) May 15, 2025
“With lessons learned from the Houston measles detection event, we are now working with our public health partners to gather data on the current measles outbreak in West Texas,” lead researcher Michael Tisza, an assistant professor of molecular virology and microbiology at Baylor College of Medicine in Houston, said in a news release.
“Our program has been monitoring measles in wastewater from those sites as well, hoping the information can help officials get ahead of this virus,” Tisza said.
The sampled Houston treatment plans help more than 218,000 people, according to the researchers.
Researchers found that testing wastewater before an outbreak revealed that these methods can prepare officials for an infectious disease.
Wastewater Testing: A Promising Public Health Tool
“Systematically sequencing the genetic material in wastewater reveals dynamic changes in human viruses circulating in a community,” senior researcher Anthony Maresso, chair of molecular virology and microbiology at Baylor, said in a news release.
“Importantly, analyzing these viral changes in wastewater can improve our understanding of outbreaks and transmission and inform public health preparedness, just as one uses meteorological data to better understand and predict weather patterns to anticipate potentially dangerous conditions,” Maresso said.
According to the researchers, there had not been any measles viruses found in any of the 821 wastewater samples collected in Houston in the past 31 months.
“Because no other cases have been reported and the detections occurred in the same area where the travelers resided, it is reasonable to assume that the measles signal detected in wastewater is from the two infected cases, which underscores the high sensitivity of the method,” Maresso said.
Vaccination Still the Best Defense
Co-researcher Eric Boerwinkle, dean of the UTHealth Houston School of Public Health, said that “this work underscores the ability of sophisticated wastewater analyses to serve as an early detection system benefitting public health, healthcare, and communities in preventing a measles outbreak in Houston.”
If they haven’t already, Boerwinkle advised individuals to acquire the measles vaccine, as reported by HealthDay.
The best way to stop the contagion of measles is the MMR vaccine, since it has already proven to be both safe and effective.
Health
Your Smartphone Might Predict How Well You Recover from Injury

With more smartphone data, there will be better ways to predict and guide recovery in orthopedics.
United States: According to a study published on May 9 in the Journal of Bone & Joint Surgery, smartphone data — including step count, walking speed, and gait — can predict how well someone recovers from bone or hip injuries. The findings suggest that mobility patterns before an injury may offer powerful insights into a patient’s post-surgical progress, as reported by HealthDay.
Data That Speaks Volumes
The study, led by Dr. Brian Shear at the University of Maryland Medical Center, followed 107 adults who had previously undergone surgery for a broken leg or hip. Using data from participants’ Apple iPhones, researchers analyzed their pre-injury activity levels — specifically, their steps, speed, and gait — and compared it with their recovery progress.
Patients who were more active before their injury tended to recover faster and return to mobility more easily. “This novel approach has the power to reshape how orthopedic care is delivered,” Dr. Shear explained.
A New Era of Personalized Rehab
The study found that patients with higher daily step counts before their injury had better recovery outcomes. Likewise, those with faster walking speeds and consistent gait patterns pre-injury also healed more effectively — highlighting the predictive value of everyday mobility metrics.
With this knowledge, doctors are able to plan treatments better, detect possible issues in patients’ progress earlier, and give patients more precise timelines for recovery.
Expanding the Technology’s Use
Senior researcher Nathan O’Hara, associate professor at the University of Maryland School of Medicine, announced plans to broaden the study’s scope to include other areas of orthopedics like sports medicine, joint replacement, and shoulder or foot surgery, as reported by HealthDay.
An app is also under development to support this initiative, with multicenter clinical trials expected to begin later this year.
-
News4 weeks ago
FDA Approves Self-Injectable Vyvgart Hytrulo for gMG and CIDP
-
News4 weeks ago
FDA’s Food Safety Testing Suspended Due to Budget Cuts
-
News3 weeks ago
Anesthesiologists Face Increasing Risk of Head Injuries in the Operating Room
-
News4 weeks ago
CDC Panel Recommends New Vaccines for RSV, Meningitis, and Chikungunya
-
News3 weeks ago
Novavax Nears Full FDA Approval for COVID Vaccine
-
News3 weeks ago
Toxic Bedtime? New Research Reveals Chemical Risks in Infant and Toddler Mattresses
-
News3 weeks ago
Overuse of Antibiotics in Early Childhood Linked to Higher Risk of Asthma and Allergies
-
News4 weeks ago
Heavy Weed Use Tied to Dopamine Surges, Psychosis